PT - JOURNAL ARTICLE AU - Nash, Rebecca K AU - Lambert, Ben AU - N’Guessan, Raphael AU - Ngufor, Corine AU - Rowland, Mark AU - Oxborough, Richard AU - Moore, Sarah AU - Tungu, Patrick AU - Sherrard-Smith, Ellie AU - Churcher, Thomas S TI - Systematic review of the entomological impact of insecticide-treated nets evaluated using experimental hut trials in Africa AID - 10.1101/2021.04.07.21254306 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.07.21254306 4099 - http://medrxiv.org/content/early/2021/04/08/2021.04.07.21254306.short 4100 - http://medrxiv.org/content/early/2021/04/08/2021.04.07.21254306.full AB - Background Resistance of anopheline mosquitoes to pyrethroid insecticides is spreading rapidly across sub-Saharan Africa, diminishing the efficacy of insecticide-treated nets (ITNs) — the primary tool for preventing malaria. The entomological efficacy of indoor vector control interventions can be measured in experimental hut trials (EHTs), which are specially designed to quantify the protection provided under controlled conditions. Experimental hut structures resemble local housing but allow collection of surviving exiting mosquitoes as well as dead or dying mosquitoes. There is a need to understand how the spread of resistance changes ITN efficacy and to elucidate factors influencing EHT results, including differences in experimental hut construction and design features, to support the development of novel vector control tools.Methods A comprehensive database of EHTs was compiled and summarised following a systematic review to identify all known trials investigating ITNs or indoor residual spraying (IRS) across sub-Saharan Africa. This analysis focuses on EHTs investigating ITNs and uses Bayesian statistical models to characterise the complex interaction between ITNs and mosquitoes, the variability between studies, and the impact of pyrethroid resistance.Results As resistance rises, the entomological efficacy of ITNs declines. They induce less mortality and are less likely to deter mosquitoes from entering huts. Despite this, ITNs continue to offer considerable personal protection by reducing mosquito feeding until resistance reaches high levels. There are clear associations between the different entomological impacts of ITNs, though there is still substantial variability between studies, some of which can be accounted for by hut design. The relationship between EHT outcomes and the level of resistance (as measured by discriminating dose bioassays) is highly uncertain.Conclusions The meta-analyses show that EHTs are an important reproducible assay for capturing the complex entomological efficacy of ITNs on blood-feeding mosquitoes. The impact of pyrethroid resistance on these measures appears broadly consistent across a wide geographical area once hut design is accounted for, suggesting results can be extrapolated beyond the sites where the trials were conducted. Further work is needed to understand factors influencing EHT outcomes and how the relationship between outcomes and resistance varies when different methods are used to assess the level of resistance in wild mosquito populations. This will allow more precise estimates of the efficacy of these important vector control tools.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work was supported by the Innovative Vector Control Consortium (IVCC), the Wellcome Trust [200222/Z/15/Z] MiRA and the UK Medical Research Council (MRC)/ UK Department for International Development (DFID) under the MRC/DFID Concordat agreement.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Unpublished studies were approved by the Ethics Review Committee of the London School of Hygiene & Tropical Medicine.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData extracted from published studies will be provided in the supplementary material of the published manuscript. Unpublished data that support the findings of this study will be available from the corresponding author upon reasonable request and subject to agreement with the data owners.